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Abstract
K-Pal regulates the basal transcription of the K and L subunits of eukaryotic initiation factor two (eIF-2), a rate-limiting
enzyme for the initiation of protein biosynthesis. We recently showed that its global function may be to modulate the
expression of key metabolic genes in response to cellular proliferation. In this paper, we examined a potential molecular
mechanism by which K-Pal may achieve this function. When overexpressed, K-Pal upregulated protein synthesis and growth,
but downregulated the cell cycle. The mechanism for the increased protein synthesis and growth appeared to be a
transcriptional upregulation of the eIF-2K and eIF-2L genes. The mechanism for the cell cycle downregulation appeared to
be a transcriptional downregulation of E2F-1, a transcription factor that regulates genes required for cell cycle progression
beyond the G1/S interphase. Specifically, an apparently modified species of K-Pal bound to the eIF-2 promoters and induced
transcriptional upregulation, whereas, an apparently unmodified species of the K-Pal bound to the E2F-1 promoter and
induced transcriptional downregulation. By this mechanism, K-Pal may participate in coordinating the regulation of global
protein synthesis, growth and the cell cycle; a regulation that is essential to cellular differentiation. ß 2000 Elsevier Science
B.V. All rights reserved.
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1. Introduction
In a normal course of life, cells grow, divide, dif-
ferentiate, senesce and die. Of these, cellular growth
and division require a signi¢cant increase in global
protein synthesis. To distinguish cell growth from
cell division cycle, we de¢ne cellular growth based
on the ideas of Swann [1], as the increased synthesis
of macromolecules that lead to increased cell size,
but not necessarily cell division. We de¢ne the cell
division cycle (or cell cycle) as the cyclical pathway in
which complex interactions between cyclins, cyclin-
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dependent kinases and other speci¢c proteins drive a
cell to duplicate its genome and divide. Normally,
the relationship between protein synthesis, growth
and the cell cycle is such that activation of cellular
growth drives global protein synthesis, which in turn
drives growth, and growth drives cell division cycle
or proliferation [2^4]. Growth is so dependent on
protein synthesis that it is often measured by the
amount of protein synthesized. Similarly, cell divi-
sion cycle is so dependent on growth that it normally
does not occur without the attainment of a critical
rate of growth [4,5]. For example, if the growth of
yeast cells is limited, the cells arrest their division
cycle [2]. Indeed, all eukaryotic cells wait at the start
or restriction point until they attain the required crit-
ical rate of growth before initiating entry into S-
phase. This coordinated control ensures that cellular
protein content doubles before the cell commits itself
to genomic duplication and mitosis. Sometimes, the
relationship between protein synthesis and the cell
cycle is not direct. For example, during cellular dif-
ferentiation and senescence, cells withdraw from
cycle, but do not abort global protein synthesis. In-
stead, cells adjust the rate either downward, upward
or not at all, depending on the species and tissue type
[4,6,7]. Yeast and Drosophila cells blocked in cell
cycle progression continue to grow, indicating that
they maintain high rates of global protein synthesis
[2,8,9]. How global protein synthesis, growth and cell
cycle are coordinately regulated in all these instances
is unknown, even though much is now known about
translation and cell cycle controls.
The eukaryotic cell cycle is primarily controlled at
the restriction point or checkpoint 1 (C-point1)
[4,10,11]. Upon receiving positive growth signals
such as growth factors, competent quiescent cells be-
gin to grow. They wait at C-point1 until their growth
rate exceeds the required minimum and then commit
to replicate DNA and divide. C-point1 is apparently
maintained by the upregulated expression of the cy-
clin-dependent kinase inhibitors (CDKIs), p21, p27,
p57 and the p16 family. CDKIs inactivate G1 cyclin-
CDK activities [12^15] and, thereby, prevent the hy-
perphosphorylation of the retinoblastoma family
proteins (pRB, p107, and p130). The pRBs thus can-
not release bound E2Fs, a class of ¢ve transcription
factors (E2F-1 through E2F-5) that regulate the ex-
pression of genes required for cell cycle progression
beyond G1 [16^19]. Prior to commitment, the E2Fs
are bound by hypophosphorylated pRBs. The result-
ing complexes engage E2F binding sites on target
gene promoters and repress transcription, thereby
preventing cells from entering S-phase. After com-
mitment, a decline in the activities of CDKIs frees
CDKs to hyperphosphorylate pRBs and release
E2Fs to transactivate the expression of genes that
drive cell cycle progression beyond G1. E2F-1 is
the best-studied member of these transcription fac-
tors. Its overexpression in quiescent cells is su⁄cient
to induce S-phase entry, proliferation and apoptosis.
It is the only member that possesses apoptosis as well
as cell cycle regulatory activities [18,20,21]. Further-
more, its apoptosis and transcription activities ap-
pear to be required for the regulation of cell prolif-
eration and tumor formation. For example, E2F13=3
mice exhibit testicular atrophy, apparently due to a
lack of cell proliferation, but develop aggressive lung
tumors apparently due to a failure to eliminate aber-
rant cells by apoptosis [22^24]. E2F-1’s prominent
roles in cell cycle control, makes it a potential can-
didate to participate in the coordinated regulation of
protein synthesis, growth and the cell cycle.
In eukaryotes, the translation pathway is catalyzed
by a set of enzymes called eukaryotic translation ini-
tiation factors (eIF). Prominent among them is eIF-
2, a heterotrimer consisting of K, L and Q subunits.
eIF-2 catalyzes a rate-limiting initiation step of trans-
lation; i.e. the binding of initiator met-tRNA to the
40S ribosomal subunit [25,26]. For this reason, the
overall rate of translation in most cells is dependent
on eIF-2. Its K subunit is a target for post-transla-
tional modi¢cations that lead to the regulation of
protein synthesis in response to growth arrest, di¡er-
entiation, viral infection, and metabolic changes [27^
30]. Furthermore, quiescent T-cells and human ¢bro-
blasts responding to growth activation upregulate
eIF-2K mRNA expression [31,32]. Thus, cells appear
to adjust global protein synthesis in response to
growth activation by regulating the expression of
eIF-2K. We searched for a transcriptional regulatory
link between global protein synthesis and the cell
cycle by examining eIF-2K transcription factors. K-
Pal, a transcription factor for both eIF-2K and eIF-
2L appeared poised to mediate growth responses be-
cause of the following [33]. (1) Potential regulatory
targets for K-Pal are genes that are involved in cel-
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lular proliferation or the growth-responsive metabol-
ic pathways: energy transduction, translation and
DNA replication. (2) Both the Drosophila and sea
urchin homologs of K-Pal, P3A2 and ewg, are
growth and developmental transcription factors
[34,35].
To determine if K-Pal can mediate a coordinated
regulation of protein synthesis, growth and the cell
cycle, we studied the e¡ects of its overexpression on
cellular translation, growth and division cycle activ-
ities. We report here that overexpression of K-Pal
increased both protein synthesis and growth, but re-
tarded cell cycle progression. The molecular bases for
these e¡ects are: (1) overexpression of K-Pal upregu-
lated the transcription of eIF-2K and eIF-2L genes
leading to the upregulation of cellular protein con-
tent and growth; and (2) overexpression of K-Pal led
to an increase in a putative unmodi¢ed K-Pal species
that repressed E2F-1 gene transcription leading to a
retarded cell proliferation.
2. Materials and methods
2.1. Cell culture and antibodies
TF-1 is an erythroleukemic cell line that is depen-
dent on IL-3 for growth and proliferation. It was
purchased from ATCC. The cells were grown at a
density of 0.1^0.7U106 CFU/ml in RPMI 1640
containing 10% FBS, 5 ng/ml human IL-3 and the
antimicrobials; penicillin, streptomycin and ampho-
tericin B. This medium was designated complete
RPMI growth medium. Incubation conditions were
37‡C and 5% CO2. K562, like TF-1, is an erythro-
leukemic cell line. It was grown as previously de-
scribed [36]. The cell line, 293, was purchased from
ATCC, and were grown in DMEM supplemented
with 10% FBS, penicillin, streptomycin and ampho-
tericin B.
Polyclonal antibodies against K-Pal were produced
using the peptides; K-PPEP3, 242-NVRSDVRT-
EEQKQRVSWTQA261 and K-PPEP4; 35SMLSAD-
EDSPSSPEDTSYDDSDILNST63. Analysis of the
K-Pal polypeptide by PCGENE identi¢ed the stron-
gest immunogenic epitopes within these peptides.
The antibodies were produced by Advanced Chem-
Tech (Louisville, KY) and puri¢ed by ammonium
sulfate precipitation (45%) and protein A agarose
a⁄nity columns.
2.2. Recombinant DNA constructs
The K-Pal expression vectors LS51 and LS12,
which overexpressed K-Pal sense and K-Pal antisense
mRNA, respectively, were constructed by inserting
the K-Pal cDNA into the inducible expression vector,
POPRSVCAT(LacSwitchO^ Kit, Stratagene, La Jolla,
CA), using Stratagene’s procedure. In LS51, the K-
Pal cDNA is oriented in the sense direction, whereas,
in LS12, it is oriented in the antisense direction.
POPRSVCAT promoter carries the lactose operon
operator switch; co-expressed repressor protein binds
to it and inhibits transcription, and added IPTG
counteracts the binding and induces transcription
of the K-Pal cDNA. The K-Pal overexpression vector,
pCIPal27, used in transient overexpression experi-
ments, was constructed using pCIneo vector (Prom-
ega, Madison, WI).
The wild-type E2F1 promoter construct, wE2-
F1Luc, was kindly provided by Dr. J. Nevin of
The Department of Genetics, Duke University Med-
ical Center, Durham, NC (E2F1Luc-728, [37]). The
construct consists of an 800-bp fragment of the hu-
man E2F-1 promoter inserted into pGL2 vector
(Promega, Madison, WI) to drive luciferase expres-
sion. The mutant, mE2F1Luc, was generated by mu-
tating the wild-type at seven bases that are critical to
K-Pal binding using Quick Change mutagenesis kit




bases are shown in Fig. 5. The mutant bases are
indicated above in lower case letters and have been
shown to be less preferred in these positions [33]. The
wild-type eIF-2K construct, weIF2KLuc, consists of a
700-bp fragment of the human eIF-2K promoter in-
serted into pGL2 vector to drive luciferase expres-
sion, and the mutant version, meIF2KLuc, was gen-
erated using the above Quick Change mutagenesis
kit. The eIF-2L promoter constructs, weIF2LLuc
(wild-type) and meIF2LLuc (mutant) were generated
as described previously [38].
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2.3. Stable overexpression clones
To generate stable clones overexpressing K-Pal,
3.0U106 TF-1 cells were cotransfected with 11.5 Wg
each of LS51 and P3P-SS (an expression vector for
the lactose repressor protein), using the calcium
phosphate-BES precipitation method [39]. To gener-
ate stable clones overexpressing K-Pal antisense
RNA, 3.0U106 TF-1 cells were similarly cotrans-
fected with 11.5 Wg each of LS12 and P3P-SS. Vec-
tor-transfected control cells were similarly generated
using 11.5 Wg each of POPRSVCAT and P3P-SS.
Seventy two hours after transfection, double trans-
fectants were selected by growing in the presence of
300 Wg/ml of Hygromycin and 400 Wg/ml of G418 for
14 days. This pool of cells was diluted to one cell/200
Wl with conditioned RPMI growth medium contain-
ing 200 Wg/ml of G418, and used to seed 96-well
plates at one cell/well. The plates were incubated
under standard growth conditions for 2 weeks with
frequent replacement of medium. G418-resistant
clones were transferred to larger plates, expanded
further and evaluated for K-Pal expression using
Western blot, Northern blot and EMSA assays.
The clones selected for this study were: SC50, which
overexpressed K-Pal mRNA and protein; ASC2,
which overexpressed K-Pal antisense RNA, but
underexpressed K-Pal protein; and vTF1 which was
a vector-transfected control.
2.4. Transient expression assays
Transfection of 293 cells was performed using
Superfect transfection reagent (Qiagen, Santa Clari-
ta, CA). The manufacturer’s instructions were fol-
lowed except that culture dishes were seeded with
15 000 CFU/cm2 and transfection complexes were
formed using 0.07 Wg DNA per cm2 of plate and a
Superfect/DNA ratio of 4. Cells were incubated in
the DNA/Superfect complexes for 6 h before they
were rinsed and grown in DMEM growth medium
for 12^48 h. Afterwards, the cells were harvested and
processed for cell extract and luciferase expression
using Promega’s (Madison, WI) Luciferase assay
kit. Humanized green £uorescent protein was used
to assess transfection e⁄ciencies which averaged
70%.
2.5. Preparation of K-Pal
To prepare bacterially-produced recombinant K-
Pal (brK-Pal), the full-length K-Pal cDNA was cloned
into the bacterial expression vector, pRSET A (Invi-
trogen, La Jolla, CA). The cDNA was cloned in
frame with an upstream sequence that encoded a
metal-binding histidine tag fused to the N-terminus
of the rK-Pal. Ni2 a⁄nity column puri¢cation of
brK-Pal was done as recommended. Native K-Pal
(nK-Pal) was prepared as described [33]. In vitro-
translated K-Pal (ivtK-Pal) was prepared by in vitro
transcription of the K-Pal cDNA followed by trans-
lation in rabbit reticulocyte lysate (RRL) using
Promega’s TNT kit.
2.6. Preparation of nuclear extracts/protein assays
Nuclear extracts were prepared as reported by
Dignan et al. [40], with the following exceptions.
Lysis bu¡er (bu¡er A) contained 10 mM HEPES
(pH 7.9), 10 mM KCl, 0.8 mM spermidine, 0.1 mM
EDTA, 1.0 mM DTT, 1.0 mg/ml PEFABLOCK
(Boehringer Mannheim, Indianapolis, IN). Nuclear
extraction bu¡er (bu¡er C) contained 20 mM
HEPES (pH 7.9), 470 mM NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 25% glycerol, 2 mM DTT and
1.0 mg/ml PEFABLOCK. Protein concentrations
were determined by the BCA Protein Assay method
(Pierce, Rockford, IL).
2.7. Western and Northern blotting assays
These were done using standard methods [39]. For
Western blots, electrophoresed proteins were trans-
ferred onto 0.2-Wm PVDF membrane (Bio-Rad, Her-
cules, CA) using semi-dry transfer equipment (Bio-
Rad), and probed with the appropriate antibodies.
Blots were developed with Amersham’s (Arlington
Height, IL) ECL reagents. For Northern blots, 20
Wg of total RNA were diluted with 2URNA sample
loading bu¡er consisting of 2UMOPS bu¡er, 13%
Ficol, 7 M urea, 0.03% each of Bromphenol blue
and xylene xylenol ¡. The samples were electropho-
resed in formaldehyde agarose gels, transferred onto
0.45-Wm Magnacharge membranes (Micron Separa-
tion, Westboro, MA), and probed with 32P-labeled
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speci¢c probes. Bands were quanti¢ed by volume in-
tegration using Phosphoimaging equipments (Molec-
ular Dynamics, Sunnyvale CA).
2.8. Growth pro¢le
Cycling cells were washed twice in growth me-
dium. Aliquots were treated with Trypan blue dye
and viable cells were counted with a hemocytometer.
Triplicate T-25 £asks were seeded with 1.0U106
CFU of either vTF1, SC50 or ASC2 cells in 10 ml
of complete RPMI medium containing 1.7 mM
IPTG. The £asks were incubated at standard growth
conditions for 72 h during which viable cells were
counted. Viable cells as a percentage of the initial
seed were plotted against time to generate a growth
curve.
2.9. Apoptosis pro¢le
SC50, ASC2 and vTF1 cells were grown in the
presence of 1.7 mM IPTG for 72 h to induce max-
imal expression of K-Pal RNA. The cells were
washed twice in RPMI growth medium containing
1.7 mM IPTG, 7.5% FBS and no IL-3, and re-sus-
pended at a concentration of 1.0U106 CFU/ml. For
each clone, T-25 £asks were seeded in triplicate with
1.0U106 CFU suspended in 10 ml of the wash me-
dium. The £asks were incubated at standard condi-
tions for 72 h during which viable cells were counted.
Viable cells as a percentage of the initial seed were
plotted against time to generate a death curve.
2.10. Electrophoretic mobility shift assays
This was performed as reported before [33].
2.11. Modi¢cation/dephosphorylation of K-Pal
To modify brK-Pal, 10 Wg of brK-Pal was mixed
with 30 Wl of RRL and 1Ubu¡er M, in a total vol-
ume of 60 Wl. The mixture was incubated at 30‡C for
30 min and then stored at 380‡C until used. Bu¡er
M (1U) contained 20 mM HEPES (pH 7.5), 50 mM
KCl, 10 mM MgCl2 and 1 mM DTT.
Dephosphorylation reactions were performed in a
40-Wl reaction volume containing 7 ng of puri¢ed
native K-Pal (or 10 Wg of brK-Pal), 1.0 mg/ml BSA,
20 mM MnCl2, protein phosphatase 1Q (Life Tech-
nologies, Gaithersberg, MD) or 2A1 (Calbiochem,
San Diego, CA) and 1Uphosphatase bu¡er (20
mM HEPES, 5.0 mM MgCl2, 1.0 mM DTT, 0.1
mM EGTA). The reaction was incubated at 30‡C
then stored at 380‡C until use.
2.12. In vitro transcription assay
brK-Pal was incubated at 25‡C for 20 min in a
reaction mixture containing 1Utranscription bu¡er,
16% glycerol, 600 ng linearized template and 40 U of
RNasin (Promega, Madison, WI) in a total volume
of 25 Wl. This allowed brK-Pal to bind to its E2F1-
Pal1 site. During the incubation, a cocktail contain-
ing the following ingredients in a total volume of
25 Wl was prepared: 1Utranscription bu¡er; 20 WM
ZnCl2 ; 500 WM each of ATP, GTP and CTP; TF-1
nuclear extract (80 Wg protein), H2O, and 50 WM of
K-32P-labeled UTP. This cocktail was added to the
¢rst reaction mixture after the 20-min incubation.
The resulting 50 Wl reaction mixture was incubated
at 30‡C for 45 min and extracted by adding 150 Wl of
10 mM EDTA, 200 Wl of Trizol (Life Technologies,
Gaithersburg, MD) and 100 Wl of chloroform, fol-
lowed by vigorous vortexing and a 10-min centrifu-
gation in a refrigerated microfuge. The upper aque-
ous phase was carefully transferred into a sterile
tube, precipitated with 400 Wl of isopropanol and
15 Wl of sterile 5.0 M ammonium acetate, and the
pellet washed with 70% ETOH. The pellet was solu-
bilized 50 Wl of RNA loading bu¡er and electropho-
resed in a 4.5% denaturing acrylamide gel for 8 h.
After ¢xing and rinsing, the gel was dried and tran-
scripts viewed by standard autoradiography.
1Utranscription bu¡er contained 20 mM HEPES
(pH 7.5), 50 mM KCl, 10 mM MgCl2 and 1 mM
DTT. Labeled UTP contained 50 WM cold UTP
and 1 Wl of [K-32P]UTP (3000 Ci/mmol). All reagents
and supplies were sterile and RNAse-free.
3. Results
3.1. Stable overexpression/underexpression of K-Pal in
TF-1 cells
Our previous studies indicated that K-Pal, a tran-
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scription factor for eIF-2K and eIF-2L, may link the
transcriptional regulation of key metabolic genes to
cellular growth and development. In this study, we
examined a speci¢c metabolic pathway, protein bio-
synthesis, to see if and how it is linked by K-Pal to
the cell division cycle. We did this by overexpressing
or underexpressing K-Pal in the human cell lines, TF-
1 and 293, and assessing the e¡ects on pertinent cel-
lular parameters. The K-Pal cDNA was inserted into
the vector POPRSVCAT as described in Section 2 to
generate constructs which expressed either the sense
or antisense mRNA when transfected into cells. The
sense construct was transferred into TF-1 cells to
generate the stable clone, SC50, which overexpressed
both the K-Pal mRNA and protein. The antisense
construct was transferred into TF-1 cells to generate
the stable clone, ASC2, which overexpressed the K-
Pal antisense mRNA and, hence, underexpressed the
protein. The empty POPRSVCAT vector was simi-
larly transferred to generate the vector-transfected
control cells, v-TF1.
SC50, ASC2 and v-TF1 cells were treated with 1.7
mM IPTG either to induce optimal expression of K-
Pal, or to ensure that the cells received similar treat-
ments. Cells were harvested at various times and
processed for total RNA and nuclear extracts. West-
ern blot analysis of the nuclear extracts (Fig. 1A)
showed that at 72 h after IPTG treatment, SC50
overexpressed the recombinant K-Pal (rK-Pal) protein
by about 5-fold relative to v-TF1. However, the
overexpression was barely inducible because the lac-
tose operator switch that was used to control the
expression was leaky. Northern blot analysis con-
¢rmed a correlating increase in K-Pal mRNA (data
not shown), indicating that the increased expression
of K-Pal was transcriptionally driven. In contrast,
ASC2 inducibly underexpressed the native protein
(nK-Pal) by about 6-fold compared to the v-TF1
control, indicating that ASC2 overexpressed K-Pal
antisense RNA inducibly. Northern blot analysis
also con¢rmed a correlating increase in the antisense
RNA (data not shown). The two clones, SC50 and
ASC2, were subsequently used to evaluate the e¡ects
of stable overexpression of K-Pal in TF-1 cells.
3.2. Overexpression of K-Pal results in increased
eIF-2 transcription and changes in cellular protein
synthesis
K-Pal regulates the transcription of eIF-2K and 2L
genes and thus regulates the expression of functional
eIF-2, a rate-limiting initiation factor for protein
synthesis [36,38]. Overexpressed K-Pal, therefore,
can modulate the transcription of the eIF-2K and
2L genes and a¡ect cellular global protein synthesis.
To assess these e¡ects, SC50, ASC2 and v-TF1 were
treated with IPTG to induce maximal K-Pal RNA
overexpression, and the treated cells were harvested
at various times and used to prepare total RNA.
Aliquots of the 72-h cultures were also used to pre-
pare whole cell extracts for measuring cellular pro-
tein content. Results of Northern blot analysis
showed that, after 48 h of induction, eIF-2K and
eIF-2L transcripts increased by about 3-fold in
Fig. 1. Stable clones of TF-1 cells inducibly express K-Pal.
SC50, ASC2 and v-TF1 (control) cells were grown in the pres-
ence of 1.7 mM IPTG, either to induce maximal expression of
K-Pal, or to ensure that they all received identical treatment.
Nuclear extracts were prepared at the indicated times and ana-
lyzed for K-Pal by Western immunoblotting. (A) Inducible over-
expression of K-Pal in SC50 cells. Each lane contained 40 Wg of
proteins. (B) Inducible underexpression of K-Pal in ASC2 cells.
Each lane contained 100 Wg of proteins. The numbers to the
left indicate molecular mass.
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SC50 as compared to v-TF1 (Fig. 2A). Thus, the
overexpressed K-Pal upregulated the transcription
of these genes as expected. In contrast, eIF-2K and
eIF-2L transcripts in ASC2 were unchanged or de-
creased by less than 10%. This indicated that K-Pal
underexpression did not signi¢cantly repress the
basal transcription of the eIF-2K and eIF-2L genes
as would be expected. Our unpublished data indicate
that residual K-Pal in the ASC2 cells was still su⁄-
cient to maintain basal transcription rate.
The observed e¡ects on the transcription of eIF-2K
and eIF-2L genes were re£ected at the level of trans-
lation. Assessment of total protein in the cells
showed that SC50 contained 219 pg of protein per
CFU in comparison to 180 pg/CFU for v-TF1 and
173 pg/CFU for ASC2 (Fig. 2C). Similar results were
obtained for other clones: SC29 and SC40 that sta-
bly overexpressed K-Pal, contained more proteins,
and ASC1 and ASC3 that stably underexpressed K-
Pal, contained slightly less proteins than v-TF1. To-
gether, these results indicate that overexpression of
K-Pal induced the upregulation of eIF-2 subunit
genes leading to a 20% increase in cellular global
protein synthesis. In contrast, underexpression of
K-Pal did not decrease the transcription of eIF-2
subunit genes, and consequently, did not signi¢cantly
decrease protein synthesis from the basal level.
3.3. Overexpression of K-Pal retards cell proliferation,
whereas underexpression stimulates proliferation
The rate at which a cell grows is a function of the
rate of global protein biosynthesis [3,5]. Normally,
growth is coupled to the cell division cycle such
that when a growing cell exceeds a critical size, cell
division occurs, thereby maintaining a uniform cell
size. Under normal conditions, therefore, increased
growth results in increased cell size, increased cell
C
Fig. 2. Overexpressed K-Pal upregulated the transcription of
eIF-2K and eIF-2L genes and cellular protein content. Total
RNA was prepared from cells grown as described for Fig. 1,
and was analyzed for eIF-2K and eIF-2L transcripts by North-
ern blotting. Each lane contained 20 Wg of total RNA. (A) Ex-
pression pro¢le of eIF-2K and eIF-2L in SC50. (B) Expression
pro¢le of eIF-2K and eIF-2L in ASC2. (C) Cellular protein con-
tents at the 72nd hour. The data represent averages of six ex-
periments.
BBAMCR 14562 30-12-99
B.J.S. E¢ok, B. Safer / Biochimica et Biophysica Acta 1495 (2000) 51^68 57
division and increased cell number. Conversely, de-
creased growth leads to decreases in these parame-
ters. Since overexpression of K-Pal in TF-1 cells led
to increased protein synthesis and underexpression
led to near-normal synthesis, we determined how
these changes a¡ected cellular growth and cell divi-
sion. Growth and cell division were assessed by de-
termining changes in cell number and size in re-
sponse to the induction of K-Pal overexpression.
The results show that SC29 and SC50 cells that over-
expressed K-Pal, were retarded in cell proliferation as
compared to v-TF1 (Fig. 3A). The cells, however,
increased in size (Fig. 3B). Similar growth and pro-
liferation pro¢les were also obtained for another
overexpressing clone, SC40, and G418-resistant
pools. These results indicate that cells of this clone
grew at an increased rate, but the growth was some-
what uncoupled from cell division cycle since it led to
increased cell size and not increased proliferation. In
agreement, ASC2 and ASC3 that underexpressed K-
Pal, showed increased proliferation and decreased
size as compared to v-TF1 (Fig. 3). Similar growth
and proliferation pro¢les were also obtained for an-
other underexpressing clone, ASC1, and G418-resis-
tant pools. Transiently transfected 293 cells also
showed retarded proliferation in response to K-Pal
overexpression, indicating that the above e¡ect on
growth is not limited to TF-1 cells. These results
suggest that K-Pal positively regulates cellular
growth, but negatively regulates the cell cycle.
C
Fig. 3. (A) Cell proliferation was retarded by overexpression,
but stimulated by underexpression of K-Pal. SC29, SC50,
ASC2, ASC3 and v-TF1 cells were grown as described in Sec-
tion 2, and aliquots were analyzed at the indicated times to
generate the growth curve (see Section 2). Each data point rep-
resents the average of six experiments. (B) Cell size was in-
creased by overexpression, but decreased by underexpression of
K-pal. v-TF1, SC50 and ASC2 cells were grown for 72 h as de-
scribed in Section 2 for Fig. 3A. The cells were photographed
directly in the incubation £ask without any processing, using a
Zeiss light microscope set at U20 magni¢cation. Each image
was printed at U66 magni¢cation (Reduced to U43 for publi-
cation).
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3.4. The increased proliferation was accompanied by
increased apoptosis
Since cell cycle perturbation is often accompanied
by changes in the rate of apoptosis, we evaluated the
rate of apoptosis of SC29, SC50, ASC2, ASC3 and
v-TF1 cells in response to K-Pal overexpression.
These cells, like the parental TF-1, are normally de-
pendent on IL-3 for survival and proliferation. Fol-
lowing IL-3 withdrawal, the cells withdraw from
cycle but remain viable for about 24 h. Afterwards,
a majority of them apoptose within the following 48
h [41]. Fig. 4 shows that SC29 and SC50 that over-
expressed K-Pal, behaved similarly to v-TF-1 in that
they withdrew from cycle within the ¢rst 24 h and
apoptosed at about the same rate thereafter. G418-
resistant pools and SC40 that also overexpressed K-
Pal, gave similar results (data not shown). In con-
trast, ASC2 and ASC3 that underexpressed K-Pal,
consistently failed to withdraw from cycle within 24
h of IL-3 withdrawal. Most notably, they continued
to proliferate during the ¢rst 24 h and thereafter
apoptosed at a faster rate than v-TF1. G418-resistant
pools and ASC1 that also underexpressed K-Pal,
gave similar results (data not shown). Thus, under-
expression of K-Pal apparently led to: (1) fast cell
cycling; (2) failure to withdraw from cell cycle in
response to the absence of growth signal; and (3)
increased rate of apoptosis. These e¡ects are very
similar to those observed when E2F-1 is overex-
pressed in cells. When overexpressed, E2F-1 drove
quiescent cells into cycle, and increased the rate of
apoptosis [20,21,42^46]. The premature entry of the
quiescent cells into cycle indicates a failure to with-
draw from cell cycle in the absence of growth signal.
E2F-1 mediated apoptosis is often dependent on cer-
tain experimental conditions, such as low serum.
Similarly, the increased apoptosis of the K-Pal under-
expressing clones, ASC2 and ASC3, were dependent
on the absence of serum. Taken together, the above
results suggest that underexpressing K-Pal leads to
the upregulation of E2F-1 and a consequent increase
in cell proliferation when the growth signal, IL-3,
was present, or a consequent increase in apoptosis
when the growth signal was absent.
3.5. K-Pal interacts di¡erentially on the eIF-2K and
E2F-1 gene promoters
The above results suggest that K-Pal negatively
regulates E2F-1 expression. In agreement, SC50 cells
that stably overexpressed K-Pal, moderately downre-
gulated E2F-1 mRNA and ASC2 that underex-
pressed K-Pal, moderately upregulated the mRNA
(data not shown). To con¢rm this and to elucidate
the molecular mechanism involved, a series of assays
were performed. We started out by searching the
human E2F-1 promoter for K-Pal DNA-recognition
sites. Three sites were identi¢ed within the proximal
region. One of these, E2F1-Pal1, is embedded in a
region known to have strong in£uence on E2F-1
transcription, and has previously been shown to me-
diate transcriptional repression of the E2F-1 pro-
moter [47]. Using EMSA, the K-Pal binding charac-
teristics of this site were compared to those of the
high a⁄nity site on eIF-2K promoter (eIF-2PalH). K-
Pal preparations used in the binding studies were:
native K-Pal (nK-Pal) that was puri¢ed from K562
nuclear extract; in vitro translated K-Pal (ivtK-Pal)
that was histidine-tagged rK-Pal translated in vitro in
rabbit reticulocyte lysate (RRL); and a⁄nity puri¢ed
bacterially produced rK-Pal (brK-Pal) that was histi-
dine-tagged homodimeric rK-Pal produced in Esche-
richia coli. The results (Fig. 5B) show that neither the
nK-Pal, nor the ivtK-Pal, bound the E2F1-Pal1 site
even though they bound eIF-2PalH with high a⁄n-
ity. In contrast, brK-Pal bound both sites with sim-
Fig. 4. The increased proliferation was accompanied by in-
creased apoptosis. Cells grown for 72 h in the presence of 1.7
mM IPTG, were processed and analyzed for apoptosis (see Sec-
tion 2). The data represents averages for six experiments. Cells
underexpressing K-Pal failed to exit the cell cycle in the absence
of IL-3, and apoptosed faster than control cells.
BBAMCR 14562 30-12-99
B.J.S. E¢ok, B. Safer / Biochimica et Biophysica Acta 1495 (2000) 51^68 59
Fig. 5. K-Pal binds to its sites on eIF-2K and E2F-1 promoters with di¡erent a⁄nities. (A) Location and sequence of the upstream K-
Pal binding site on human E2F-1 promoter. The top schematic illustrates the locations of three K-Pal binding sites E2F1-Pal1, E2F1-
Pal2 and E2F1-Pal3. The sequence of E2F1-Pal1 is shown and is then compared to those of the K-Pal consensus and the high-a⁄nity
site on the eIF-2K promoter (eIF2-PalH). *, indicates bases critical to binding. (B) Autoradiograph of EMSA comparing the a⁄nities
of eIF2-PalH and E2F1-Pal1 for nK-Pal, ivtK-Pal and brK-Pal. Both nK-Pal and ivtK-Pal bound eIF2-PalH with high a⁄nity
(Kd = 111 pM), but failed to bind E2F1-Pal1. In contrast, brK-Pal bound both sites. (C) EMSA demonstrating the speci¢city of bind-
ing of brK-Pal to E2F1-Pal1. The binding was not disrupted by 1000-fold excess cold mutant eIF2-PalH (lane 2), but was disrupted
by either 100-fold excess cold wild-type eIF2-PalH (lane 3) or mutant E2F1-Pal1 (lane 4).
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ilar a⁄nities. In competition assays, 1000-fold excess
cold mutant eIF-2PalH failed to disrupt binding of
the brK-Pal to E2F1-Pal1 (Fig. 5C, lane 2), whereas
100-fold excess cold wild-type eIF-2PalH probe abol-
ished the binding (lane 3). Also, when the E2F1-Pal1
site was mutated at bases which were previously
shown to be critical to K-Pal binding, the binding
was completely abolished (lane 4). These results con-
¢rm the speci¢city of the binding of brK-Pal to
E2F1-Pal1.
As the cDNA templates for the ivtK-Pal and brK-
Pal were identical, but ivtK-Pal acquired the binding
characteristics of nK-Pal, and brK-Pal did not, then
either ivtK-Pal had been modi¢ed by something in
the RRL in which it was translated, or brK-Pal was
modi¢ed in bacteria so that it behaved di¡erently.
Both possibilities were tested. First, phosphorylation
is the most common modi¢cation that cells use to
alter transcription factor activity, and brK-Pal may
have been inappropriately phosphorylated in bacte-
ria. Therefore, brK-Pal was dephosphorylated with
protein phosphatase 1 (PP1), protein phosphatase
II (PP2) or lambda protein phosphatase (VPP), and
then retested for binding by EMSA. The treated and
the untreated proteins behaved similarly with regard
to binding a⁄nities towards E2F1-Pal1 and eIF-
2PalH probes (data not shown). Therefore, the abil-
ity of brK-Pal to bind to both probes in Fig. 5B was
not due to inappropriate phosphorylation in bacte-
ria. Secondly, brK-Pal was treated with catalytic
amounts of RRL to see if it could be modi¢ed to
acquire the binding characteristics of the native pro-
tein. The results (Fig. 6A) showed that brK-Pal ac-
quired the binding characteristics of nK-Pal in that it
decreased a⁄nity for the E2F1-Pal1 probe, but sig-
ni¢cantly increased a⁄nity for eIF-2PalH. These re-
sults indicate that the switch in binding a⁄nities was
caused by a modi¢cation of the brK-Pal homodimer
in RRL. The modi¢cation was not phosphorylation
because neither additional ATP (Fig. 6A, lanes 4, 5,
9, 10) nor other common nucleotide triphosphates
(data not shown) had any e¡ect on the extent of
the K-Pal modi¢cation. The modi¢ed rK-Pal acquired
an apparent electrophoretic mobility that was inter-
mediate to nK-Pal and brK-Pal (Fig. 6A,B), indicat-
ing that it could be a heterodimer. Together, the
results in this section show that, K-Pal interacts
with its binding site on E2F-1 promoter di¡erently
than it interacts with those on the eIF-2K promoter.
They also imply that nK-Pal could be a heterodimer
that binds eIF-2PalH site with high a⁄nity but have
very low a⁄nity for the E2F1-Pal1 site, and that only
Fig. 6. Modi¢ed brK-Pal exhibited di¡erential binding a⁄nities
towards eIF2-PalH and E2F1-Pal1. brK-Pal was treated with
RRL as described in Section 2. (A) Autoradiograph of EMSA
showing binding activities of the modi¢ed brK-Pal towards
eIF2-PalH and E2F1-Pal1. The modi¢ed brK-Pal showed in-
creased binding a⁄nity for eIF-2PalH (lanes 2^5), but de-
creased a⁄nity for E2F1-Pal1 (lanes 7^10). The indicated ATP
values were added to the modi¢cation reactions to determine if
the mechanism was kinase dependent. (B) Autoradiograph of
EMSA comparing the mobilities of nK-Pal, brK-Pal and modi-
¢ed brK-Pal. The samples were electrophoresed for twice as
long as in A. The modi¢ed brK-Pal has a mobility that appears
to be intermediate to nK-Pal and brK-Pal.
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Fig. 7. Binding of UMK-Pal to E2F-1Pal1 site repressed transcription from E2F-1 promoter. (A) Autoradiograph of 32P-labeled tran-
scripts generated by in vitro transcription from E2F-1 promoter. Linearized wE2F1Luc vector was transcribed in vitro in the presence
of various amounts of brK-Pal as described in Section 2. As controls, linearized mE2F1Luc and HIV-LTR vectors were also tran-
scribed. As shown, nanogram quantities of brK-Pal repressed E2F-1 driven transcription. (B) Plots of luciferase activities assessing the
e¡ects of rK-Pal overexpression on transcription driven by E2F-1, eIF-2K, and eIF-2L promoters. The cell line, 293, was co-transfected
with the following pairs of promoter/expression vectors: weIF2KLuc/pCIneo (a), weIF2KLuc/pCIPal27 (b), meIF2KLuc/pCIPal27 (c),
weIF2LLuc/pCIneo (d), weIF2LLuc/pCIPal27 (e), meIF2LLuc/pCIPal27 (f), wE2F1Luc/pCIneo (g), wE2F1Luc/pCIPal27 (h), mE2-
F1Luc/pCIPal27 (i) ; which are described in Section 2. After 48 h, the cells were processed and assayed for transient luciferase activity.
In response to rK-Pal overexpression, weIF2KLuc and weIF2LLuc upregulated transcription 3-fold, but wE2F1Luc downregulated
transcription 5-fold. (C^E) Extent of rK-Pal overexpression in 293 cells. Autoradiographs of Northern blot (C), Western blot (D) and
EMSA (E) are shown. Phosphoimager analysis of the Northern blot indicated a 20-fold overexpression of rK-Pal.
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K-Pal homodimer binds to the E2F1-Pal1 site with
high a⁄nity.
3.6. The di¡erential interactions of K-Pal on eIF-2K
and E2F-1 promoters mediate opposite
transcriptional e¡ects
The observed di¡erential binding a⁄nities of K-Pal
can potentially be responsible for the di¡erential ex-
pression of the eIF-2 and E2F-1 genes and the cor-
responding di¡erential e¡ects on cell growth and
proliferation rates. If so, binding of K-Pal to the
eIF-2K promoter would upregulate transcription,
but binding to the E2F-1 promoter would repress
transcription. To examine this, we ¢rst examined
the e¡ect of rK-Pal on the in vitro and in vivo tran-
scription from the E2F-1 promoter. For the in vitro
transcription, linearized wE2F1Luc, a luciferase re-
porter construct driven by the human E2F-1 pro-
moter, was transcribed using TF-1 nuclear extract.
The results (Fig. 7A) show that nanogram quantities
of brK-Pal repressed transcription from the E2F-1
promoter in a concentration-dependent manner;
with 300 ng repressing by 40% and 2000 ng by
95%. The repression was alleviated when we used
mE2F1Luc, a mutant construct that could no longer
bind brK-Pal with high a⁄nity, indicating that the
repression was mediated via binding of brK-Pal to
the E2F1-Pal1 site. Additionally, transcription from
HIV-1 LTR that lacks authentic K-Pal sites, was not
a¡ected by 1000 ng of the brK-Pal. In vivo transcrip-
tion was assessed by transient transfection assays.
When the K-Pal-overexpressing vector, pCI-Pal27,
and E2F1Luc promoter constructs were cotrans-
fected into 293 cells, the results (Fig. 7B) show that
cells cotransfected with wE2F1Luc and pCI-Pal27
repressed E2F1 transcription by about 5-fold com-
pared to control cells that were cotransfected with
wE2F1Luc and the empty expression vector, pCI-
neo. When mE2F1Luc and pCI-Pal27 were cotrans-
fected, the repression was relieved and transcription
increased moderately by two-fold, indicating that the
repression was mediated by the E2F1-Pal1 site.
Co-transfection of K-Pal expression vector and lu-
ciferase constructs of eIF2K and eIF-2L promoters
into 293 cells showed that transcription from the
wild-type promoters was stimulated by about
3-fold. Conversely, transcription from the mutant
promoters that could no longer bind K-Pal with
high a⁄nity, were inhibited by about 4^5-fold. Taken
together, the results of transcription assays con¢rm
that binding of K-Pal to E2F1-Pal1 repressed the
transcription of E2F-1 gene. Also, in agreement
with earlier work [36,38], binding of K-Pal to the
eIF-2K and eIF-2L promoters stimulated transcrip-
tion. Fig. 7C^E shows that the rK-Pal was signi¢-
cantly overexpressed in the 293 cells as assessed by
Northern blotting (C), Western blotting (D) and
EMSA (E). Phosphoimager analysis of the Northern
blot gave a 20-fold overexpression.
3.7. Unmodi¢ed nK-Pal binding activity is increased in
K-Pal overexpressing cells
The results of the above binding studies and un-
published data suggest that there are two forms of
nK-Pal dimers in cells: modi¢ed K-Pal (MK-Pal) and
unmodi¢ed K-Pal (UMK-Pal). According to Figs. 5B
and 6 MK-Pal appears to be a heterodimer and binds
preferentially to eIF-PalH, and UMK-Pal appears to
be a homodimer like brK-Pal, and may be the only
form that binds to the E2F1-Pal1 site with high af-
¢nity. The data also suggests that UMK-Pal is
present at only trace level in cells, and that the steady
state concentration of MK-Pal far exceeds that of
UMK-Pal. By overexpressing K-Pal, the level of
UMK-Pal may have increased beyond normal, lead-
ing to a downregulation of E2F-1 gene transcription
(Fig. 7). To determine the level of UMK-Pal binding
activity in cells and whether this activity was in-
creased in response to rK-Pal overexpression, its
binding activity to E2F1-Pal1 probe was assessed
by EMSA using nuclear extracts from 293 cells tran-
siently overexpressing K-Pal. The results (Fig. 8A)
show ¢rstly that UMK-Pal binding activity in 293
cells was generally at trace level compared to MK-
Pal (Lanes 6 vs. 1). Secondly, the binding activity of
UMK-Pal was signi¢cantly increased in response to
K-Pal overexpression (lanes 6 vs. 7). Lanes 8^10
show that even a 1000-fold excess of cold mutant
eIF-PalH failed to disrupt binding of UMK-Pal to
E2F1-Pal1 probe, even though 100-fold excess of
the cold wild-type eIF2-PalH probe abolished the
binding. Thus the demonstrated binding was K-Pal
speci¢c. Fig. 8B shows that UM-K-Pal binding activ-
ity was at trace level in TF-1 cells also, and increased
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Fig. 8. UMK-Pal is signi¢cantly upregulated in response to rK-Pal overexpression. (A) Autoradiograph of EMSA illustrating binding
activities of both MK-Pal and UMK-Pal in response to rK-Pal overexpression in 293 cells. Each lane contained 5 Wg of nuclear extract
proteins. Lanes 1 and 2 indicate a signi¢cant overexpression of both MK-Pal and UMK-Pal as detected by their eIF2-wPalH binding
activities. Lanes 3^5 con¢rm the speci¢city of the binding since binding was una¡ected by 1000-fold excess of cold eIF2-mPalH, but
was abolished by 100-fold excess of cold E2F1-wPal1. Lanes 6 and 7 indicate a signi¢cant increase in UMK-Pal as detected by its
E2F1-wPal1 binding activity. Lanes 8^10 con¢rm the speci¢city of the binding since binding was una¡ected by 1000-fold excess of
cold eIF2-mPalH, but was abolished by 100-fold excess of cold eIF2-wPalH probe. (B)Autoradiograph of EMSA illustrating increased
E2F-1Pal1 binding activity of UMK-Pal in SC50 cells (lane 3). In agreement, ASC2 showed a decreased UMK-Pal (lane 4). Each lane
contained 10 Wg of nuclear extract proteins. (C) Autoradiograph of EMSA assessing the E2F-1Pal1 binding activities of UMK-Pal in
the cancer cell lines; NTF-1, Y79 and SKBR-3 (lanes 1^3). For comparison, the corresponding eIF-2PalH binding activities of MK-
Pal are shown in lanes 4^6. Lanes 7^9 show UMK-Pal activities in T cell nuclear extracts and lanes 10^12 show the corresponding
MK-Pal binding activities in the same samples. Each lane contained 5 Wg of protein.
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in SC50 cells that stably overexpressed PK-Pal. In
tandem, the activity decreased in ASC2 cells that
stably underexpressed K-Pal. Thus UMK-Pal in TF-
1 cells also increased in response to K-Pal overexpres-
sion. The presence of only trace UMK-Pal in TF-1
and 293 cells most likely explains why relatively
small changes in cellular levels of K-Pal was able to
induce observable changes in the proliferation rates
of the cells.
Assay of two other cancer cell lines, (Y79 and
SKBR-3) showed similar trace levels of UMK-Pal
(Fig. 8C). Normal activated human T-lymphocytes
also contained relatively trace levels of UMK-Pal ex-
cept that, on average, the levels were 3^5-fold greater
than those of cancer cells. In all cases, though, the
level of UMK-Pal was proportional to that of MK-
Pal (Fig. 8C). This indicates that the two forms of
the protein are at steady state with one another in
vivo. The lower, more-abundant, binding activity
marked UN in Fig. 8A is considered non-speci¢c
since it was not competed away by cold probe.
4. Discussion
The transcription factor, K-Pal, regulates the ex-
pression of eIF-2K and eIF-2L, and is implicated in
coordinating the regulation of key metabolic genes in
response to changes in the growth status of the cell
[33]. We have studied how its overexpression a¡ects
the regulation of key genes in a speci¢c metabolic
pathway, protein biosynthesis, and how the e¡ects
correlate with changes in cell growth and division
cycle. When overexpressed, K-Pal di¡erentially regu-
lated cellular protein synthesis and proliferation ac-
tivities: It upregulated protein synthesis but down-
regulated proliferation. The molecular basis for the
increased protein synthesis was probably the tran-
scriptional upregulation of the K and L subunits of
eIF-2 genes (Figs. 2 and 7, and [38]). The molecular
basis for the downregulation of proliferation appears
to be the transcriptional inhibition of E2F-1 gene.
This negative regulation appears to be mediated by
a functional K-Pal binding site located 210 bp up-
stream of the ¢rst transcription start site on human
E2F-1 promoter. Although this site should bind K-
Pal with high a⁄nity based on predictions from pre-
vious kinetic studies [33], it surprisingly showed neg-
ligible binding to MK-Pal. In contrast, it bound
UMK-Pal readily (Fig. 5B). Moreover, this binding
mediated a transcriptional downregulation (Fig. 7)
that contrasts with the transcriptional upregulation
observed for the binding of MK-Pal to sites on the
eIF-2 promoter (Fig. 7, and [38]).
How K-Pal discriminates between the two types of
sites and exerts opposite transcriptional e¡ects is un-
known. It is likely that heterodimerization with an-
other protein and the unique architecture of the eIF-
2 and E2F-1 sites play important roles. Nevertheless,
these opposite transcriptional e¡ects may explain the
opposite phenotypic changes reported earlier. Over-
expression of K-Pal in TF-1 cells likely resulted in
elevated MK-Pal and UMK-Pal (Figs. 1A, 7C^D
and 8A). These bound to and upregulated the tran-
scription of eIF-2 subunit genes, leading to their in-
creased expression and increased protein synthesis.
Because UMK-Pal also bound to its E2F1-Pal1 site
and downregulated the expression of E2F-1 gene, cell
cycle progression was retarded. Thus, increased pro-
tein synthesis failed to drive increased cell prolifera-
tion. Underexpression of K-Pal predictably resulted
in the decreased levels of both forms of K-Pal (Figs.
1B and 8B). In the experiments reported here, the
decrease in MK-Pal was insu⁄cient to decrease the
transcription of eIF-2 subunit genes below basal lev-
el. Consequently, neither protein synthesis nor
growth was signi¢cantly repressed. However, the de-
crease in UMK-Pal was su⁄cient to relieve whatever
repression the normally trace level of UMK-Pal ex-
erts on the expression of E2F-1 gene. This likely led
to the upregulation of E2F-1 expression with an at-
tendant increase in proliferation. The associated in-
crease in the rate of cell division in the face of a
normal rate of growth most likely resulted in the
smaller sizes of ASC2 cells that underexpressed K-
Pal.
Our model lacks direct evidence that the regulation
of E2F-1 by K-Pal is solely responsible for the ob-
served e¡ects of K-Pal overexpression. As such, we
cannot rule out the possibility that other mechanisms
are responsible. An appropriate experiment is to
overexpress K-Pal in E2F-1 de¢cient background to
see if the e¡ects are abrogated. We plan to address
this question in future experiments using transgenic
and knockout models, since human E2F-1 de¢cient
cell lines are not available.
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The mechanism described above may participate in
coordinating cellular global protein synthesis, growth
and division cycle activities during di¡erentiation
and after cells have terminally di¡erentiated. Di¡er-
entiating vertebrate and invertebrates cells must ¢rst
exit their division cycle during these stages [4,48].
Permanent, terminally di¡erentiated cells such as
neurons and myocytes, maintain high metabolic ac-
tivity, renew their components and can increase their
size in response to increased growth or functional
demands [4]. These activities require high levels of
translational activity and, as such. They can mount
up high levels of global protein synthesis even
though they are non-mitotic. We note that skeletal
muscle tissue, which is populated with terminally dif-
ferentiated myotubes, overexpress K-Pal mRNA.
Furthermore, SC50 clones upregulated the expres-
sion of p27kip that e¡ects cell cycle exit in di¡erenti-
ating, terminally di¡erentiated and senescent cell (¢g-
ures not shown). Another situation in which the
above mechanism can apply is the coordinated regu-
lation of protein synthesis, growth and cell prolifer-
ation in the imaginary disks of the developing Dro-
sophila. When Weigmann et al. [9] blocked cell
division in the developing Drosophila wing imaginary
disk, cell growth continued, resulting in fewer larger
cells, but a normal disk size. These cells apparently
continued with high rates of global protein synthesis
resulting in their larger sizes. Whether it is di¡eren-
tiation or developmental patterning, K-Pal likely par-
ticipates in the transcriptional repression of E2F-1
gene and couples this to the transcriptional modula-
tion of eIF-2 genes. By this mechanism, K-Pal may
coordinate the regulation of cellular global protein
synthesis and cell cycle exit during these processes.
The mechanism may explain the previously reported
roles of K-Pal homologs in Drosophila and sea urchin
embryogenesis [34,35]. E2F1 transcription has also
been shown to be partially repressed by pRB-E2F
complexes that bind to autoregulatory E2F sites on
the E2F1 promoter [49^53].
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